Artwork
iconShare
 
Manage episode 524316827 series 3694347
Content provided by ZeptoMetrix. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ZeptoMetrix or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Phage-like particle (PLP) technology is reshaping how the diagnostics field approaches RNA controls, and this episode explores the story behind it. Hosts Dr. Sophie New, PhD, and Richard Keitch talk with Dr. Murugan Subbiah, DMV, MS, PhD, DACVM, Principal Scientist at ZeptoMetrix, about the real-world challenges that sparked the development of PLP, from avian flu outbreaks to COVID-19.

He breaks down how PLP enables labs to access safe, stable, non-infectious RNA controls quickly and reliably.

Tune In to Learn About:

  • What PLP is and how it’s engineered
  • Its impact on PCR, multiplex assays, and point-of-care testing
  • Opportunities in RNA-based diagnostics and research, metagenomics, and transcriptomics
  • How PLP supports rapid response during emerging outbreaks

Like this episode? Text us your thoughts >>

  continue reading

3 episodes